Acceleris Capital
VC Fund
Manchester, United Kingdom
Acceleris Capital is a VC fund in Manchester focused on Biotechnology and Health Care. Acceleris Capital arrange new capital for SME's and have direct investment in several technology based companies. They serve funding, investment and advisory needs from their office in central Manchester. Their USP is taking companies from startup through to exit, not only adding comfort to their introduced investors, but also providing ongoing mentoring and support at the most crucial time of an SMEs lifecycle.
- Total investments:
- 17
- Last investment:
- Lead investor:
- 12%
Last updated:
For AI agents: llms.txt
Industries Acceleris Capital invests in
Stages Acceleris Capital invests in
Countries Acceleris Capital invests in
Round sizes
Round size
- Venture - Series Unknown
- $1.5M–$8.1M
Investment Focus
Industry
- Biotechnology 5 (29%)
- Health Care 3 (18%)
- Manufacturing 3 (18%)
- Pharmaceutical 3 (18%)
- Farming 2 (12%)
Stage
- Venture - Series Unknown 8 (47%)
- Seed 4 (24%)
- Funding Round 3 (18%)
Country
- United Kingdom 9 (53%)
- Australia 1 (6%)
- Singapore 1 (6%)
- United States 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Reacta Healthcare develops diagnostic solutions and challenge meals for food allergy testing and clinical research. | $1.5M / Venture - Series Unknown / Sep 12, 2022 | ||
| Power Roll Limited was established to develop and commercialise its highly innovative proprietary energy storage and energy generation technologies. Power Roll technologies exhibit a range of significant benefits and advantages over existing technologies such that it is likely that the technology can prove extremely disruptive across a wide rangeof applications and markets. Power Roll has a strong intellectual property portfolio, with 15 different patent families already established. These patent families are spread across all three technologies with five directly related to Energy Storage, nine related to Solar PV and one focusing on the nano-barrier technology. | $4.2M / Venture - Series Unknown / Feb 19, 2021 | ||
| Reacta Biotech has been established to develop, manufacture and commercialise oral food challenge materials to pharmaceutical standards of Good Manufacturing Practice (GMP). | $1.5M / Venture - Series Unknown / Apr 21, 2020 | ||
| Reacta Healthcare develops diagnostic solutions and challenge meals for food allergy testing and clinical research. | $1.5M / Venture - Series Unknown / Apr 21, 2020 | ||
| Vertical Future is a technology company focused on building a better, more sustainable urban food production and supply system. | $4.9M / Seed / Oct 08, 2019 | ||
| The Frank Food Company is a social enterprise supporting regional farmers. | Venture - Series Unknown / Jan 01, 2019 | ||
| ADC Bio is developing new process technology to help drug developers meet conjugation process challenges in the testing and production of new antibody drug conjugate (ADC)-based anti cancer drugs. The technology signals faster, simpler and less costly development for an exciting new family of drugs. | $8.1M / Venture - Series Unknown / Sep 25, 2017 | ||
| The novel and broadly validated Redox Switch™ approach allows Redag Crop Protection to begin with best in class crop protection products and find new intellectual property that supports development of novel agrochemicals. These properties have shorter less costly development cycles bringing rapid innovation to the industry. There is a growing needfor new products as older ones are withdrawn either for safety reasons or because resistance has developed that reduces performance. | $2M / Venture - Series Unknown / Sep 19, 2017 | ||
| Apex Molecular a leading provider of specialist chemistry services to the pharmaceutical, biotechnology and applied chemistry sectors. | Venture - Series Unknown / Oct 06, 2016 | ||
| The novel and broadly validated Redox Switch™ approach allows Redag Crop Protection to begin with best in class crop protection products and find new intellectual property that supports development of novel agrochemicals. These properties have shorter less costly development cycles bringing rapid innovation to the industry. There is a growing needfor new products as older ones are withdrawn either for safety reasons or because resistance has developed that reduces performance. | $2M / Venture - Series Unknown / Mar 03, 2016 | ||
| See all 17 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Acceleris Capital invest in?
Acceleris Capital invests primarily in Biotechnology, Health Care and Manufacturing startups, most often at Venture - Series Unknown and Seed stage. Most of the 17 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Acceleris Capital invest in?
Acceleris Capital typically joins rounds of $1.5M–$8.1M at Venture - Series Unknown. These are whole funding-round sizes, not Acceleris Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Acceleris Capital took part in.
When did Acceleris Capital last invest?
The most recent investment recorded for Acceleris Capital closed in Sep 2022. Shizune tracks 17 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
